A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144

NCT04689035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues
Tolerance

Interventions

DRUG: AVLX-144
DRUG: Placebo

Sponsor

Avilex Pharma